These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8931722)

  • 21. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereospecific synthesis of a novel farnesyl protein transferase inhibitor, valinoctin A and its analogues.
    Tsuda M; Muraoka Y; Takeuchi T; Sekizawa R; Umezawa K
    J Antibiot (Tokyo); 1996 Oct; 49(10):1031-5. PubMed ID: 8968397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Kettler K; Sakowski J; Silber K; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2003 Apr; 11(7):1521-30. PubMed ID: 12705292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-thiol farnesyltransferase inhibitors: evaluation of different AA(X)-peptidomimetic substructures in combination with arylic cysteine replacements.
    Sakowski J; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2002 Apr; 335(4):135-42. PubMed ID: 12112033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diastereoselective syntheses of new analogues of the farnesyltransferase inhibitor RPR 130401.
    Pichon N; Harrison-Marchand A; Mailliet P; Maddaluno J
    J Org Chem; 2004 Oct; 69(21):7220-7. PubMed ID: 15471472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. II. Structural elucidation of pepticinnamin E.
    Shiomi K; Yang H; Inokoshi J; Van der Pyl D; Nakagawa A; Takeshima H; Omura S
    J Antibiot (Tokyo); 1993 Feb; 46(2):229-34. PubMed ID: 8468236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
    Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
    Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UCF116, new inhibitors of farnesyltransferase produced by Streptomyces.
    Hara M; Soga S; Itoh M; Shono K; Eishima J; Mizukami T
    J Antibiot (Tokyo); 2000 Jul; 53(7):720-3. PubMed ID: 10994815
    [No Abstract]   [Full Text] [Related]  

  • 31. 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency.
    Bell IM; Gallicchio SN; Abrams M; Beese LS; Beshore DC; Bhimnathwala H; Bogusky MJ; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hamilton KA; Hartman GD; Heimbrook DC; Homnick CF; Huber HE; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Robinson R; Rodrigues AD; Taylor JS; Walsh ES; Williams TM; Zartman CB
    J Med Chem; 2002 Jun; 45(12):2388-409. PubMed ID: 12036349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple and efficient synthesis of the ras farnesyl-protein transferase inhibitor chaetomellic acid A.
    Argade NP; Naik RH
    Bioorg Med Chem; 1996 Jun; 4(6):881-3. PubMed ID: 8818238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of Ras farnesyltransferases.
    Tamanoi F
    Trends Biochem Sci; 1993 Sep; 18(9):349-53. PubMed ID: 8236454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.
    Qian Y; Vogt A; Sebti SM; Hamilton AD
    J Med Chem; 1996 Jan; 39(1):217-23. PubMed ID: 8568811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gerfelin, a novel inhibitor of geranylgeranyl diphosphate synthase from Beauveria felina QN22047. II. Structural elucidation.
    Zenitani S; Shindo K; Tashiro S; Sekiguchi M; Nishimori M; Suzuki K; Imoto M
    J Antibiot (Tokyo); 2003 Jul; 56(7):658-60. PubMed ID: 14513911
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ras farnesyltransferase: a new therapeutic target.
    Leonard DM
    J Med Chem; 1997 Sep; 40(19):2971-90. PubMed ID: 9301658
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
    Mitsch A; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paeciloquinones A, B, C, D, E and F: new potent inhibitors of protein tyrosine kinase produced by Paecilomyces carneus. II. Characterization and structure determination.
    Fredenhagen A; Hug P; Sauter H; Peter HH
    J Antibiot (Tokyo); 1995 Mar; 48(3):199-204. PubMed ID: 7730152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
    Lombardo LJ; Camuso A; Clark J; Fager K; Gullo-Brown J; Hunt JT; Inigo I; Kan D; Koplowitz B; Lee F; McGlinchey K; Qian L; Ricca C; Rovnyak G; Traeger S; Tokarski J; Williams DK; Wu LI; Zhao Y; Manne V; Bhide RS
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1895-9. PubMed ID: 15780629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.